Navigation Links
Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season
Date:7/18/2011

eling and other matters that could affect the availability or commercial potential of such products candidates, the absence of guarantee that the products candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives, the Group's ability to benefit from external growth opportunities as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in Sanofi's annual report on Form 20-F for the year ended December 31, 2010. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.

Contact:
Sanofi Pasteur US Media Relations
Donna Cary
T. (570) 957-0717
donna.cary@sanofipasteur.com
www.sanofipasteur.us


'/>"/>
SOURCE Sanofi Pasteur
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
5. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
6. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
7. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
8. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
9. Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
10. Sanofi-aventis Stands Behind the Safety of Lantus(R)
11. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 UBM Medica ... – a new online community and information resource for ... manage and treat their patients with neurological disorders ... with an aging population, necessitates greater access to dedicated ...  Key statistics on neurological conditions include: , ...
(Date:7/23/2014)... , July 23, 2014 Research and ... Electrocardiograph (ECG) Market by Product, End-user & by Lead ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... segmented into three major segments, namely, holter monitor, resting, ... was valued at $3,683 million in 2013 and is ...
(Date:7/23/2014)... /PRNewswire-iReach/ -- The Centers for Medicare & Medicaid Services ... Improvement Organization (QIN-QIO) contract to a partnership led by ... August 1, WVMI will launch Quality Insights Quality Innovation ... Pennsylvania , Delaware , ... Network will engage providers and the community in multiple, ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3Announcing a New Regional Approach to Medicare Quality Improvement 2
(Date:7/23/2014)... (PRWEB) July 23, 2014 Obtaining insurance ... for the average consumer. The Quotes Pros company is ... all 50 states this year to make research faster ... are issuing the rates information are actual agencies that ... underwritten inside the U.S. An advantage to adults who ...
(Date:7/23/2014)... July 23, 2014 The National ... today a robust trial for a defined period ... risk adjusting relevant quality measures for sociodemographic factors, ... policy.     , Sociodemographic factors can be socioeconomic, e.g., ... ethnicity, and primary language. Growing evidence shows ...
(Date:7/23/2014)... Edmond, Oklahoma (PRWEB) July 23, 2014 ... North America’s leading provider of in-home care for ... Healthy Longevity Webinar Series featuring experts in a ... upcoming webinar will feature licensed clinical social worker ... the most common causes of caregiver stress and ...
(Date:7/23/2014)... 23, 2014 A new study has ... morcellator ( http://www.injurybeacon.com/power-morcellator/ ) during minimally invasive hysterectomies ... a woman’s body, Bernstein Liebhard LLP reports. The research, ... of the American Medical Association, looked at 36,000 women ... 500 U.S. hospitals from 2006 to 2012. Ninety-nine of ...
(Date:7/23/2014)... Randy Dotinga HealthDay Reporter ... A powerful drug combo may not be as effective ... on human cells suggests that one of the medications ... this study,s findings aren,t definitive, and there,s still hope ... and lumacaftor, according to the study,s senior author. ...
Breaking Medicine News(10 mins):Health News:Term Life Insurance Prices for All 50 States Now Explored at Insurer Website 2Health News:NQF Board Approves Trial Period to Test Impact of Risk Adjustment of Performance Measures for Sociodemographic Factors 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 4Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3
... previous treatments failed, trial results show , WEDNESDAY, April ... to a second-round treatment for hepatitis cures about half ... round, new research shows. , "This is the first ... standard treatment," said Dr. John G. McHutchison, associate director ...
... ... BA, RN, CIC, of Gainesville, Ga. as the 2010 recipient of the Elaine Larson ... ... Epidemiology (APIC) today announced Mary Andrus, BA, RN, CIC, of Gainesville, Ga. as the ...
... with kidney cancer, a team of researchers at Washington University ... of proteins excreted in the urine that could lead to ... research, published online in the May issue of Mayo ... in urine that appear to accurately reveal the presence of ...
... Over the past ... more than 50 percent in developing countries, bring us to the brink of polio eradication, ... ... Foundation ’s Vice President for Global Health Dr. Daniel Carucci stated, “On World Health Day ...
... ... a safe and affordable option. However, consumers need to be wary of sites ... , ... (PRWEB) April 7, 2010 -- Doctorsolve is warning consumers of the growing risk of ...
... , ... Koru Naturals, the top U.S. importer of New Zealand products, has received ... new assay and standards developed by Dr. Peter Molan. Molan Gold Standard is ... Unit, a center of excellence for the study of the health properties of ...
Cached Medicine News:Health News:New Drug Shows Promise for Curing Hepatitis C 2Health News:New Drug Shows Promise for Curing Hepatitis C 3Health News:APIC Announces Elaine Larson Lectureship Award Recipient 2Health News:APIC Announces Elaine Larson Lectureship Award Recipient 3Health News:Urine test for kidney cancer a step closer to development 2Health News:Urine test for kidney cancer a step closer to development 3Health News:United Nations Foundation Statement in Honor of World Health Day 2Health News:Real Men Don't Take Erectile Dysfunction Drugs Without a Prescription 2Health News:Real Men Don't Take Erectile Dysfunction Drugs Without a Prescription 3Health News:Koru Naturals Becomes the First U.S. Company to Import Molan Gold Standard Manuka Honey 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: